Posts for Category: ToxIC News

"As summer winds down and we head into fall, we are reminded of the season’s themes of change, reflection, and harvest. It’s a fitting time to look back at the many ways our members have contributed to the mission of ACMT and to celebrate those efforts..."

This landmark paper documents the value of medical toxicologists in improving patient outcomes, and their positive impact on population health and health care systems.

"Over the next two years of my presidency, I hope to make a meaningful impact and serve your needs to the best of my ability. My “virtual door” is always open to your questions, feedback, and ideas..."

Several members of ACMT's Toxicology Invesitgators Consortium (ToxIC) presented at the 2025 Annual Meeting for the College on Problems of Drug Dependence (CPDD) in New Orleans, LA. Presentations featured data from recent projects including ToxIC's FDA-funded Drug Overdose Toxico-Surveillance (DOTS) Reporting Program, and the NIDA-funded Fentanyl Analog (Fentalog) study.

We are pleased to share that the Toxicology Investigators Consortium (ToxIC) will be present with an exciting line-up of orginal research and poster presentations at the ACMT Annual Scientific Meeting April 4-6 in Vancouver Canada.

ACMT pivotal research article,“Medical Toxicology Consultations and Mortality Among Patients with Poisonings in the PICU,” published in JAMA Network Open.

The 2025 ACMT Annual Scientific meeting will take place in Vancouver, Canada from April 2 - 6. The program features three pre-meeting activities in addition to the main conference, exposing attendees to the latest advancements in medical toxicology research, and offering numerous opportunities for networking and engagement throughout.

ACMT was recently awarded a five-year, $1 million cooperative agreement with the Centers for Disease Control (CDC) to implement the “Strengthening the Public Health System and Services through a Capacity Building Assistance Program for Medical Toxicologists.”

ACMT's ToxIC Fentanyl Analog Study has detected medetomidine in patients seen in the ED after suspected opioid overdose. Data from this study included in a Morbidity and Mortality Weekly Report (MMWR) released by the CDC.

As the year comes to a close, we would like to take a moment to celebrate a year filled with achievements and growth!